These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 36890672)

  • 1. One for all, all for one: neuro-HIV multidisciplinary platform for the assessment and management of neurocognitive complaints in people living with HIV.
    Damas J; Darling KEA; Bidlingmeyer P; Nadin-Debluë I; Bieler M; Vollino L; Sokolov AA; Berney A; Maccaferri G; Filippidis P; Viala B; Granziera C; Dunet V; Du Pasquier R; Cavassini M
    HIV Med; 2023 Jun; 24(6):738-748. PubMed ID: 36890672
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Multidisciplinary assessment and management of neurocognitive complaints in people living with HIV].
    Damas J; Berney A; Bieler-Aeschlimann M; Cavassini M; Du Pasquier R
    Rev Med Suisse; 2023 Apr; 19(824):797-799. PubMed ID: 37133937
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cerebrospinal Fluid HIV-1 Escape in Patients With Neurocognitive Symptoms: Pooled Data From a Neuro-HIV Platform and the NAMACO Study.
    Filippidis P; Damas J; Viala B; Assal F; Nawej Tshikung O; Tarr P; Derfuss T; Oberholzer M; Jelcic I; Hundsberger T; Sacco L; Cavassini M; Du Pasquier R; Darling KEA;
    J Acquir Immune Defic Syndr; 2023 Jul; 93(3):219-228. PubMed ID: 36927958
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurocognitive impairment in treatment-experienced adults living with HIV attending primary care clinics in Zimbabwe.
    Nyamayaro P; Gouse H; Hakim J; Robbins RN; Chibanda D
    BMC Infect Dis; 2020 May; 20(1):383. PubMed ID: 32471350
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is the use of the QPC cognitive complaints questionnaire relevant for the screening strategy of HIV-Associated neurocognitive disorders?
    Zaegel-Faucher O; Laroche H; Tixier M; Morisseau V; Obry-Roguet V; Poizot-Martin I
    AIDS Care; 2021 Mar; 33(3):389-397. PubMed ID: 32279542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Neurocognitive Assessment in the Metabolic and Aging Cohort (NAMACO) study: baseline participant profile.
    Métral M; Darling K; Locatelli I; Nadin I; Santos G; Brugger P; Kovari H; Cusini A; Gutbrod K; Tarr PE; Calmy A; Lecompte TD; Assal F; Monsch A; Kunze U; Stoeckle M; Schwind M; Schmid P; Pignatti R; Di Benedetto C; Du Pasquier R; Cavassini M; ;
    HIV Med; 2020 Jan; 21(1):30-42. PubMed ID: 31589807
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HIV and Cognitive Impairment in Clinical Practice: The Evaluation of a Stepwise Screening Protocol in Relation to Clinical Outcomes and Management.
    Hakkers CS; Kraaijenhof JM; van Oers-Hazelzet EB; Visser-Meily AJMA; Hoepelman AIM; Arends JE; Barth RE
    AIDS Patient Care STDS; 2017 Sep; 31(9):363-369. PubMed ID: 28783374
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of trauma, economic hardship, and stress on neurocognition and everyday function in HIV.
    Watson CW; Sundermann EE; Hussain MA; Umlauf A; Thames AD; Moore RC; Letendre SL; Jeste DV; Morgan EE; Moore DJ
    Health Psychol; 2019 Jan; 38(1):33-42. PubMed ID: 30372103
    [TBL] [Abstract][Full Text] [Related]  

  • 9. How helpful are the European AIDS Clinical Society cognitive screening questions in predicting cognitive impairment in an aging, well-treated HIV-positive population?
    Metral M; Nadin I; Locatelli I; Tarr PE; Calmy A; Kovari H; Brugger P; Cusini A; Gutbrod K; Schmid P; Schwind M; Kunze U; Di Benedetto C; Pignatti R; Du Pasquier R; Darling K; Cavassini M;
    HIV Med; 2020 May; 21(5):342-348. PubMed ID: 31883203
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Benzodiazepine Use Is Associated With an Increased Risk of Neurocognitive Impairment in People Living With HIV.
    Saloner R; Grelotti DJ; Tyree G; Sundermann EE; Ma Q; Letendre S; Heaton RK; Cherner M
    J Acquir Immune Defic Syndr; 2019 Dec; 82(5):475-482. PubMed ID: 31714426
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic Risk Factors as Differential Predictors of Profiles of Neurocognitive Impairment Among Older HIV+ and HIV- Adults: An Observational Study.
    Pasipanodya EC; Montoya JL; Campbell LM; Hussain MA; Saloner R; Paolillo EM; Jeste DV; Letendre SL; McCutchan JA; Heaton RK; Moore DJ
    Arch Clin Neuropsychol; 2021 Feb; 36(2):151-164. PubMed ID: 31696212
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The association between depressive symptoms and neurocognitive impairment in people with well-treated HIV in Switzerland.
    Santos G; Locatelli I; Métral M; Berney A; Nadin I; Calmy A; Tarr P; Gutbrod K; Hauser C; Brugger P; Kovari H; Kunze U; Stoeckle M; Früh S; Schmid P; Rossi S; Di Benedetto C; Du Pasquier R; Darling K; Cavassini M;
    Int J STD AIDS; 2021 Jul; 32(8):729-739. PubMed ID: 33629882
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Simple screening for neurocognitive impairment in routine HIV outpatient care: is it deliverable?
    Parry S; Zetler S; Kentridge A; Petrak J; Barber T
    AIDS Care; 2017 Oct; 29(10):1275-1279. PubMed ID: 28292203
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIV-associated neurocognitive impairment in stable people living with HIV on ART in rural Tanzania.
    Sanmartí M; Meyer AC; Jaen A; Robertson K; Tan N; Mapesi H; Samson L; Ndaki R; Battegay M; Tanner M; Weisser M; Dalmau D; Letang E;
    HIV Med; 2021 Feb; 22(2):102-112. PubMed ID: 33190352
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurocognitive Functioning is Associated with Self-Reported and Performance-Based Treatment Management Abilities in People Living with HIV with Low Health Literacy.
    Fazeli PL; Woods SP; Lambert CC; Waldrop-Valverde D; Vance DE
    Arch Clin Neuropsychol; 2020 Jul; 35(5):517-527. PubMed ID: 32090235
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Screening Accuracy of Mini Addenbrooke's Cognitive Examination Test for HIV-Associated Neurocognitive Disorders in People Ageing with HIV.
    Trunfio M; De Francesco D; Vai D; Medina C; Milesi M; Domini S; Alcantarini C; Imperiale D; Bonora S; Di Perri G; Calcagno A
    AIDS Behav; 2022 Jul; 26(7):2203-2211. PubMed ID: 34982319
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Geriatric Syndromes in People Living with HIV Associated with Ageing and Increasing Comorbidities: Implications for Neurocognitive Complications of HIV Infection.
    Falutz J; Kirkland S; Guaraldi G
    Curr Top Behav Neurosci; 2021; 50():301-327. PubMed ID: 31907879
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurocognitive SuperAging in Older Adults Living With HIV: Demographic, Neuromedical and Everyday Functioning Correlates.
    Saloner R; Campbell LM; Serrano V; Montoya JL; Pasipanodya E; Paolillo EW; Franklin D; Ellis RJ; Letendre SL; Collier AC; Clifford DB; Gelman BB; Marra CM; McCutchan JA; Morgello S; Sacktor N; Jeste DV; Grant I; Heaton RK; Moore DJ;
    J Int Neuropsychol Soc; 2019 May; 25(5):507-519. PubMed ID: 30890191
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Symptoms of depression and rates of neurocognitive impairment in HIV positive patients in Beijing, China.
    Dwyer R; Wenhui L; Cysique L; Brew BJ; Lal L; Bain P; Wesselingh S; Wright EJ
    J Affect Disord; 2014 Jun; 162():89-95. PubMed ID: 24767011
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Defining neurocognitive impairment in HIV: deficit scores versus clinical ratings.
    Blackstone K; Moore DJ; Franklin DR; Clifford DB; Collier AC; Marra CM; Gelman BB; McArthur JC; Morgello S; Simpson DM; Ellis RJ; Atkinson JH; Grant I; Heaton RK
    Clin Neuropsychol; 2012; 26(6):894-908. PubMed ID: 22708483
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.